BioSpace News Archive

GlaxoSmithKline plc and Innoviva Inc., today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for once-daily fluticasone furoate/umeclidinium/vilanterol under the proposed brand name of Trelegy Ellipta for the treatment of adults with chronic obstructive pulmonary disease (COPD).

Sciton, Inc. is pleased to announce a partnership with its Women’s Health Group (WHG) division and GroupSource an industry leading group purchasing organization (GPO) providing superior service for physicians and clinics.

Egalet Corporation announced that a large Southeast regional health plan has placed SPRIX (ketorolac tromethamine) Nasal Spray in a tier 3 covered position effective immediately.

Saranas Inc., today announced the completion of a $2.8 million Series C funding round.

Kalorama Information reports that the competition in the consumables segment of the market is much more intense than that in the instrumentation market.

Bayer announced today that the U.S.Food and Drug Administration (FDA) has accepted the New Drug Application (NDA).

Receives FDA 510(k) clearance for laparoscopic inguinal hernia and laparoscopic cholecystectomy procedures

Integrated Medical Health Solutions (IMCS) has named Lori Daugherty as its Chief Executive Officer.

Revance Therapeutics, Inc. today announced that Lauren Silvernail has resigned as Revance’s Chief Financial Officer and Chief Business Officer, effective as of May 29, 2018.

On May 26, 2018, the Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was held in Shanghai. Themed on “Broader Vision, Deeper Insight”.